产品名称 | NebuSelect™ Recombinant Human EMAP-II/AIMP1, His-tag |
---|---|
目录号 | NBL-240647 |
别名 | EMAP-II/AIMP1; EMAP-2; EMAP-II; AIMP1; HLD3; SCYE1; p43 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q12904-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240647-100ug | 100ug | Inquire | Inquire | |
NBL-240647-1mg | 1mg | Inquire | Inquire | |
NBL-240647-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human EMAP-II/AIMP1, His-tag
Catalog#:
NBL-240647
Description:
NebuSelect™ Recombinant Human EMAP-II/AIMP1, His-tag(Cat#NBL-240647) is expressed in E.coli with His tag at the N-Terminus.It contains Ala2-Lys312.
Species:
Human
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 35.4 kDa. The protein migrates to 40-45 kDa based on Bis-Tris PAGE result.
Target Name:
EMAP-II/AIMP1; EMAP-2; EMAP-II; AIMP1; HLD3; SCYE1; p43
Target Information:
The potent antiangiogenic and proinflammatory protein Endothelial Monocyte Activating Polypeptide II (EMAP II) has been described as a mediator of pulmonary vascular and alveolar formation and its expression is inversely related to the periods of vascularization and alveolarization in the developing lung. Hence the study of EMAP II could play a vital role in studying and devising appropriate therapeutics for diseases of aberrant lung development, such as BPD.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.